Product Literature
| NDC | PRODUCT NAME | SELL SHEET | ||
| 17478-542-02 | Adenosine Injection, USP 2 mL 3 mg/mL Vial |  | ||
| 17478-253-10 | AK-Fluor® (fluorescein injection, USP) 5 mL 10% Single-dose Vial | | ||
| 17478-792-10 | Akten® (lidocaine hydrochloride ophthalmic gel) 5 mL 3.5% Sterile Ophthalmic Gel | | ||
| 17478-060-12 | Akwa Tears® (artificial tears) 15 mL 1.4% Ocular Lubricant Sterile Ophthalmic Solution | | ||
| 11098-060-05 | Alfenta® (alfentanil hydrochloride injection) 5 mL 500 mcg/mL Single-dose Ampule CII | | ||
| 17478-067-02 | Alfenta® (alfentanil hydrochloride injection) 2 mL 500 mcg/mL Single-dose Ampule CII | | ||
| 17478-716-10 | Apraclonidine Ophthalmic Solution, USP 5 mL 0.5% as Base Sterile Ophthalmic Solution | | ||
| 17478-716-11 | Apraclonidine Ophthalmic Solution, USP 10 mL 0.5% as Base Sterile Ophthalmic Solution | | ||
| 17478-060-12 | Artificial Tears Solution (polyvinyl alcohol ophthalmic solution) 15 mL 1.4% Ocular Lubricant Sterile Ophthalmic Solution | | ||
| 17478-214-20 | Atropine Care™ (atropine sulfate ophthalmic solution) 2 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-10 | Atropine Care™ (atropine sulfate ophthalmic solution) 5 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-12 | Atropine Care™ (atropine sulfate ophthalmic solution) 15 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-20 | Atropine Sulfate Ophthalmic Solution 2 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-10 | Atropine Sulfate Ophthalmic Solution 5 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-12 | Atropine Sulfate Ophthalmic Solution 15 mL 1% Sterile Ophthalmic Solution | | ||
| 11098-526-03 | BAL In Oil™ (dimercaprol injection, USP) 3 mL 100 mg/mL Single-dose Ampule | | ||
| 17478-715-10 | Brimonidine Tartrate Ophthalmic Solution 5 mL 0.2% Sterile Ophthalmic Solution | | ||
| 17478-715-11 | Brimonidine Tartrate Ophthalmic Solution 10 mL 0.2% Sterile Ophthalmic Solution | | ||
| 17478-715-12 | Brimonidine Tartrate Ophthalmic Solution 15 mL 0.2% Sterile Ophthalmic Solution | | ||
| 17478-931-01 | Calcitriol lnjection 1 mL 1 mcg/mL Single-dose Ampule | | ||
| 17478-080-50 | Capastat® Sulfate (capreomycin for injection, USP) 10 mL 1 g Lyophilized Vial | | ||
| 17478-714-10 | Ciprofloxacin Ophthalmic Solution, USP 5 mL 0.3% as Base Sterile Ophthalmic Solution | | ||
| 11098-507-01 | Cyanide Antidote Kit Kit Sodium Nitrite Injection, Sodium Thiosulfate Injection, Amyl Nitrite Inhalants | | ||
| 17478-892-25 | Diclofenac Sodium Ophthalmic Solution 2.5 mL 0.1% Sterile Ophthalmic Solution | | ||
| 17478-892-10 | Diclofenac Sodium Ophthalmic Solution 5 mL 0.1% Sterile Ophthalmic Solution | | ||
| 17478-515-00 | Ephedrine Sulfate Injection, USP 1 mL 50 mg/mL Single-dose Ampule | | ||
| 17478-070-35 | Erythromycin Ophthalmic Ointment, USP 3.5 g 0.5% Sterile Ophthalmic Ointment | | ||
| 17478-070-31 | Erythromycin Ophthalmic Ointment, USP 1 g 0.5% Sterile Ophthalmic Ointment | | ||
| 17478-640-10 | Fluress® (fluorescein sodium and benoxinate hydrochloride ophthalmic solution, USP) 5 mL Fluorescein Sodium 0.25% and Benoxinate HCl 0.4% Sterile Ophthalmic Solution, With Separate Sterile Dropper | | ||
| 17478-403-03 | Ful-Glo® (fluorescein sodium strips, USP) Strip 0.6 mg Individually Wrapped Sterile Ophthalmic Strips | | ||
| 17478-404-01 | Ful-Glo® (fluorescein sodium strips, USP) Strip 1.0 mg Individually Wrapped Sterile Ophthalmic Strips | | ||
| 17478-284-35 | Gentak® (gentamicin sulfate ophthalmic ointment, USP) 3.5 g 0.3% Sterile Ophthalmic Ointment | | ||
| 17478-283-10 | Gentak® (gentamicin sulfate ophthlamic solution, USP) 5 mL 0.3% Sterile Ophthalmic Solution | | ||
| 17478-283-10 | Gentamicin Sulfate Ophthlamic Solution, USP 5 mL 0.3% Sterile Ophthalmic Solution | | ||
| 17478-064-12 | Gonak™ (hypromellose ophthalmic demulcent solution) 15 mL 2.5% Sterile Hypromellose Ophthalmic Demulcent Solution | | ||
| 17478-547-01 | Granisetron Hydrochloride Injection, USP 1 mL 0.1 mg/mL Single-dose Vial | | ||
| 17478-934-01 | HydrALAZINE Hydrochloride Injection, USP 1 mL 20 mg/mL Single-dose Vial | | ||
| 17478-540-01 | Hydromorphone Hydrochloride, USP (High Potency Formulation) 1 mL 10 mg/mL Single-dose Amber Ampule CII | | ||
| 17478-540-05 | Hydromorphone Hydrochloride, USP (High Potency Formulation) 5 mL 10 mg/mL Single-dose Amber Ampule CII | | ||
| 17478-540-50 | Hydromorphone Hydrochloride, USP (High Potency Formulation) 50 mL 10 mg/mL Single-dose Vial CII | | ||
| 17478-701-02 | IC-Green™ (indocyanine green for injection, USP) 25 mg Vial and 10 mL Ampule (Solvent) 25 mg Sterile Indocyanine Green Single-dose Vials and Sterile Aqueous Solvent Ampules | | ||
| 17478-508-01 | Indigo Carmine™ (indigotindisulfonate sodium injection, USP) 5 mL 8 mg/mL Single-dose Ampule | | ||
| 17478-208-10 | Ketorolac Tromethamine Ophthalmic Solution, 0.4% 5 mL 0.4% Sterile Ophthalmic Solution | | ||
| 17478-209-19 | Ketorolac Tromethamine Ophthalmic Solution, 0.5% 3 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-209-10 | Ketorolac Tromethamine Ophthalmic Solution, 0.5% 5 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-209-11 | Ketorolac Tromethamine Ophthalmic Solution, 0.5% 10 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-717-10 | Ketotifen Fumarate Ophthalmic Solution 5 mL 0.025% Sterile Ophthalmic Solution | | ||
| 17478-420-20 | Labetalol Hydrochloride Injection, USP 20 mL 5 mg/mL Multi-dose Vial | | ||
| 17478-420-40 | Labetalol Hydrochloride Injection, USP 40 mL 5 mg/mL Multi-dose Vial | | ||
| 17478-107-20 | Levofloxacin Injection, for Intravenous Use 20 mL 25 mg/mL, Single-dose Vial (equivalent to 500 mg of levofloxacin) | | ||
| 17478-107-30 | Levofloxacin Injection, for Intravenous Use 30 mL 25 mg/mL, Single-dose Vial (equivalent to 750 mg of levofloxacin) | | ||
| 17478-106-10 | Levofloxacin Ophthalmic Solution 5 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-711-10 | Lidocaine Hydrochloride Jelly, USP 5 mL 2% Sterile Jelly | | ||
| 17478-711-30 | Lidocaine Hydrochloride Jelly, USP 30 mL 2% Sterile Jelly | | ||
| 17478-501-01 | Methylergonovine Maleate Injection, USP 1 mL 0.2 mg/mL Ampule | | ||
| 17478-061-12 | Natural Tears Solution (hypromellose and dextran solution) 15 mL 0.3% Hypromellose, 0.1% Dextran 70 Sterile Lubricant Ophthalmic Solution | | ||
| 17478-713-10 | Ofloxacin Ophthalmic Solution, USP 5 mL 0.3% Sterile Ophthalmic Solution | | ||
| 17478-713-11 | Ofloxacin Ophthalmic Solution, USP 10 mL 0.3% Sterile Ophthalmic Solution | | ||
| 17478-538-02 | Orphenadrine Citrate Injection, USP 2 mL 30 mg/mL Single-dose Vial | | ||
| 17478-704-12 | Paremyd® (hydroxyamphetamine hydrobromide and tropicamide, ophthalmic solution) 15 mL Hydroxyamphetamine Hydrobromide 1% and Tropicamide 0.25% Ophthalmic Solution | | ||
| 17478-622-35 | Sodium Chloride Ophthalmic Ointment, USP 3.5 g 5% Hypertonicity Sterile Ophthalmic Ointment | | ||
| 17478-623-12 | Sodium Chloride Ophthalmic Solution, USP 15 mL 5% Hypertonicity Eye Drops | | ||
| 11098-050-05 | Sufenta® (sufentanil citrate injection) 5 mL 50 mcg/mL Ampule CII | | ||
| 17478-061-12 | Tears Renewed® (artificial tear solution) 15 mL 0.3% Hypromellose, 0.1% Dextran 70 Sterile Lubricant Ophthalmic Solution | | ||
| 17478-933-01 | Terbutaline Sulfate Injection, USP 1 mL 1 mg/mL Single-dose Ampule | |
Don't have Adobe Acrobat or Adobe Reader? DOWNLOAD HERE